| scholarly article | Q13442814 |
| P50 | author | Franklin G. Miller | Q20855537 |
| Arlene M Davis | Q42846902 | ||
| Steven Joffe | Q44378576 | ||
| Christine Grady | Q61799788 | ||
| Nancy E Kass | Q66764484 | ||
| Benjamin S Wilfond | Q87149215 | ||
| Charles W Lidz | Q106415058 | ||
| P2093 | author name string | Daniel K Nelson | |
| Gail E Henderson | |||
| Jeffrey Peppercorn | |||
| Pamela Sankar | |||
| Michele M Easter | |||
| Nancy M P King | |||
| Larry R Churchill | |||
| Catherine R Zimmer | |||
| Barbra Bluestone Rothschild | |||
| P2860 | cites work | Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect". | Q33935724 |
| Systematic review to determine whether participation in a trial influences outcome | Q33940563 | ||
| Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism | Q33966882 | ||
| Quality of informed consent in cancer clinical trials: a cross-sectional survey | Q34104151 | ||
| False hopes and best data: consent to research and the therapeutic misconception | Q34172812 | ||
| Defining and describing benefit appropriately in clinical trials | Q34228756 | ||
| The therapeutic misconception: informed consent in psychiatric research | Q34247522 | ||
| The therapeutic misconception: problems and solutions | Q34844699 | ||
| Assessing Benefits in Clinical Research: Why Diversity in Benefit Assessment Can Be Risky | Q35564577 | ||
| Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review | Q35642930 | ||
| Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders | Q36252231 | ||
| The invisible hand in clinical research: the study coordinator's critical role in human subjects protection | Q36761053 | ||
| Re-evaluating the therapeutic misconception: response to Miller and Joffe. | Q36937047 | ||
| The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research | Q38464684 | ||
| A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials | Q39220096 | ||
| Views of American oncologists about the purposes of clinical trials | Q40614974 | ||
| Rewriting the "points to consider": the ethical impact of guidance document language | Q45856335 | ||
| Elements of style: consent form language and the therapeutic misconception in phase 1 gene transfer trials | Q45883257 | ||
| Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument. | Q46009635 | ||
| Therapeutic misconception in early phase gene transfer trials | Q47614520 | ||
| The correlation between patient characteristics and expectations of benefit from Phase I clinical trials | Q47794442 | ||
| Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients. | Q48657549 | ||
| Uncertain benefit: investigators' views and communications in early phase gene transfer trials. | Q50995109 | ||
| The impact of disease severity on the informed consent process in clinical research. | Q52049125 | ||
| Phase I cancer trials. A collusion of misunderstanding. | Q52889998 | ||
| Evaluating the therapeutic misconception | Q56786666 | ||
| Evaluating the quality of informed consent | Q57194143 | ||
| Consent forms and the therapeutic misconception: the example of gene transfer research | Q57194146 | ||
| The ubiquity and utility of the therapeutic misconception | Q57194290 | ||
| Trust, The fragile foundation of contemporary biomedical research | Q57194511 | ||
| The many meanings of care in clinical research | Q57313977 | ||
| Vulnerability to Influence: A Two-Way Street | Q57313981 | ||
| Rethinking Risk-Benefit Assessment for Phase I Cancer Trials | Q58376052 | ||
| Consensus and controversy in clinical research ethics | Q58661110 | ||
| Therapeutic misconception and the appreciation of risks in clinical trials | Q76388608 | ||
| The "inclusion benefit" in clinical trials | Q77946794 | ||
| Therapeutic misconception in clinical research: frequency and risk factors | Q79888446 | ||
| Communication and miscommunication in informed consent to research | Q81182475 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e324 | |
| P577 | publication date | 2007-11-27 | |
| P1433 | published in | PLOS MEDICINE | Q1686921 |
| P1476 | title | Clinical trials and medical care: defining the therapeutic misconception | |
| P478 | volume | 4 |
| Q57174782 | "Free Testing and PrEP without Outing Myself to Parents:" Motivation to participate in oral and injectable PrEP clinical trials among adolescent men who have sex with men |
| Q36281705 | "I passed the test!" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa |
| Q33882258 | 'Like sugar and honey': the embedded ethics of a larval control project in The Gambia |
| Q36259815 | 'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States |
| Q37621690 | A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries |
| Q90371291 | AAN position statement: Ethical issues in clinical research in neurology |
| Q36701265 | Adolescent Research Participants' Descriptions of Medical Research |
| Q36362789 | Adolescents' understanding of research concepts: a focus group study. |
| Q56526496 | An adapted instrument to assess informed consent comprehension among youth and parents in rural western Kenya: a validation study |
| Q35989895 | An approach to evaluating the therapeutic misconception |
| Q36394808 | An exploratory study of therapeutic misconception among incarcerated clinical trial participants |
| Q42619946 | An integrated systems biology approach to the study of preterm birth using "-omic" technology--a guideline for research |
| Q33857722 | An intervention to improve cancer patients' understanding of early-phase clinical trials. |
| Q47443859 | Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception? |
| Q34560093 | Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception? |
| Q36808362 | Assessing research participants' perceptions of their clinical research experiences |
| Q34385745 | Assessing the quality of informed consent in a resource-limited setting: a cross-sectional study |
| Q37461392 | Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer |
| Q39045008 | Bioethics in Practice: Therapeutic Misconception |
| Q40045748 | Cancer and bioethics: caring and consensus |
| Q84394952 | Challenges in analgesic drug development |
| Q39976746 | Changing perspectives in biobank research: from individual rights to concerns about public health regarding the return of results |
| Q39784592 | Charting a course for genomic medicine from base pairs to bedside |
| Q42368060 | Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials |
| Q35068463 | Clinical research and medical care: towards effective and complete integration |
| Q36880223 | Community-based HIV clinical trials: an integrated approach in underserved, rural, minority communities |
| Q36814749 | Conceptualizing the role of research literacy in advancing societal health |
| Q36051254 | Configuring the patient as clinical research subject in the UK national health service. |
| Q50073288 | Confronting the therapeutic misconception. |
| Q56775584 | Considering the vulnerabilities of surrogate decision-makers when obtaining consent for critical care research |
| Q35632752 | Decisional capacity and consent for schizophrenia research. |
| Q38781965 | Deep Brain Stimulation for Alzheimer's Disease: Ethical Challenges for Clinical Research |
| Q38378547 | Deep Brain Stimulation in Anorexia Nervosa: Hope for the Hopeless or Exploitation of the Vulnerable? The Oxford Neuroethics Gold Standard Framework. |
| Q36275979 | Description of the types and content of phase 1 clinical trial consent conversations in practice |
| Q46611829 | Developing Clinical Research Relationship: Views from Within |
| Q48038756 | Drug Familiarization and Therapeutic Misconception Via Direct-to-Consumer Information |
| Q93031372 | Duality of purpose: Participant and parent understanding of the purpose of genomic tumor profiling research among children and young adults with solid tumors |
| Q34308064 | Effects of group metacognitive training (MCT) on mental capacity and functioning in patients with psychosis in a secure forensic psychiatric hospital: a prospective-cohort waiting list controlled study |
| Q37058089 | Empirically-derived Knowledge on Adolescent Assent to Pediatric Biomedical Research |
| Q58671946 | En route to ethical recommendations for gene transfer clinical trials |
| Q47232050 | Enhancing patients' autonomy by involving them in research ethics committees |
| Q58281682 | Ethical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson's Disease |
| Q39661136 | Ethical challenges in conducting research on dying patients and those at high risk of dying. |
| Q47134375 | Ethical challenges involved in obtaining consent for research from patients hospitalized in the intensive care unit |
| Q96577041 | Ethical conflicts in translational genetic research: lessons learned from the eMERGE-III experience |
| Q36908952 | Ethical considerations in tissue engineering research: Case studies in translation |
| Q47180899 | Ethics in Psychiatric Research: Issues and Recommendations |
| Q53560287 | Ethics of bioengineering organs and tissues. |
| Q41171803 | Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology |
| Q47307973 | Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment |
| Q37604269 | Expectations and experiences of investigators and parents involved in a clinical trial for Duchenne/Becker muscular dystrophy. |
| Q35037745 | Experiencing everyday ethics in context: frontline data collectors perspectives and practices of bioethics |
| Q49576023 | Exploring the Gaps in Practical Ethical Guidance for Animal Welfare Considerations of Field Interventions and Innovations Targeting Dogs and Cats. |
| Q34869495 | Exploring the social meaning of curing HIV: a qualitative study of people who inject drugs in Guangzhou, China. |
| Q47611530 | Faith, Hope And (No) Clarity |
| Q90259111 | First Do No Harm: Ethical Concerns of Health Researchers That Discourage the Sharing of Results With Research Participants |
| Q37217591 | First-in-human trial participants: not a vulnerable population, but vulnerable nonetheless |
| Q33452847 | Formative Evaluation of Participant Experience With Mobile eConsent in the App-Mediated Parkinson mPower Study: A Mixed Methods Study. |
| Q34363988 | Framing expectations in early HIV cure research |
| Q33541225 | Global report on preterm birth and stillbirth (6 of 7): ethical considerations |
| Q64094002 | Going off antiretroviral treatment in a closely monitored HIV “cure” trial: longitudinal assessments of acutely diagnosed trial participants and decliners |
| Q36364604 | HIV treatment as prevention and HPTN 052. |
| Q64067960 | Health researchers' experiences, perceptions and barriers related to sharing study results with participants |
| Q58106648 | How Do Young People with Cystic Fibrosis Conceptualize the Distinction Between Research and Treatment? A Qualitative Interview Study |
| Q56785724 | How can we draw the line between clinical care and medical research |
| Q26830262 | How to share results of clinical trials with study participants? |
| Q56519092 | Indirect Benefits in HIV Cure Clinical Research: A Qualitative Analysis |
| Q58106686 | Informed Consent Forms in Oncology Research: Linguistic Tools Identify Recurrent Pitfalls |
| Q90351377 | Informed Consent in Two Alzheimer's Disease Research Centers: Insights From Research Coordinators |
| Q35746362 | Informed consent in psychiatry clinical research: A conceptual review of issues, challenges, and recommendations |
| Q92450696 | Informed consent procedure in a double blind randomized anthelminthic trial on Pemba Island, Tanzania: do pamphlet and information session increase caregivers knowledge? |
| Q92373437 | Informed consent, therapeutic misconception, and clinical trials for Alzheimer's disease |
| Q38263412 | International requirements for consent in biobank research: qualitative review of research guidelines |
| Q58255075 | Intracranial Stem Cell-Based Transplantation: Reconsidering the Ethics of Phase 1 Clinical Trials in Light of Irreversible Interventions in the Brain |
| Q30993087 | Life promises and 'failed' family ties: expectations and disappointment within a clinical trial (Ivory Coast). |
| Q35641238 | Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting. |
| Q93106408 | Marijuana use among patients with epilepsy at a tertiary care center |
| Q56775615 | Nanomedicine first-in-human research: challenges for informed consent |
| Q34415663 | Navigating the challenges of global reproductive health research |
| Q38600110 | Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium |
| Q37075880 | Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial |
| Q46119000 | One Size Fits All?: Ethical Considerations for Examining Efficacy in First-in-Human Pluripotent Stem Cell Studies |
| Q55427838 | Palliative Head and Neck Cancer Treatment for Asymptomatic Disease. |
| Q36004658 | Parents' online portrayals of pediatric treatment and research options |
| Q38240559 | Participant comprehension of research for which they volunteer: a systematic review |
| Q35785918 | Participants with schizophrenia retain the information necessary for informed consent during clinical trials |
| Q35892688 | Participants' Perceptions of Deep Brain Stimulation Research for Treatment-Resistant Depression: Risks, Benefits, and Therapeutic Misconception |
| Q35813928 | Participants' Understanding of Informed Consent in a Randomized Controlled Trial for Chronic Knee Pain |
| Q48270408 | Patient information in phase 1 trials: A systematic review |
| Q26750036 | Patient involvement in clinical research: why, when, and how |
| Q36905270 | Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer |
| Q47150619 | Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC). |
| Q36984204 | Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations |
| Q26865346 | Phase I trials of antitumour agents: fundamental concepts |
| Q37029700 | Planning for Ancillary Care Provision: Lessons From the Developing World. |
| Q37885275 | Population biobanks and returning individual research results: mission impossible or new directions? |
| Q34140645 | Problems with the consensus definition of the therapeutic misconception |
| Q97524813 | Profiling trial burden and patients' attitudes to improve clinical research in epidermolysis bullosa |
| Q48728492 | Promoting leisure participation as part of health and well-being in children and youth with cerebral palsy. |
| Q37901975 | Protecting participants of clinical trials conducted in the intensive care unit |
| Q37376616 | QUALZICE: a QUALitative exploration of the experiences of the participants from the ZICE clinical trial (metastatic breast cancer) receiving intravenous or oral bisphosphonates. |
| Q38989858 | Randomised placebo-controlled trials of surgery: ethical analysis and guidelines |
| Q26822431 | Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field |
| Q42361513 | Reducing therapeutic misconception: A randomized intervention trial in hypothetical clinical trials. |
| Q35569312 | Research biopsies in the context of early phase oncology studies: clinical and ethical considerations. |
| Q26782104 | Research participants' perceptions and views on consent for biobank research: a review of empirical data and ethical analysis |
| Q30376172 | Resurrecting the triple threat: academic social responsibility in the context of global health research |
| Q34256618 | Rethinking the therapeutic misconception: social justice, patient advocacy, and cancer clinical trial recruitment in the US safety net. |
| Q33835535 | Return of results: ethical and legal distinctions between research and clinical care |
| Q47606403 | Revisiting Expectations in an Era of Precision Oncology |
| Q49036211 | Risks and benefits of trial participation: A qualitative study of participants' perspectives in Russia. |
| Q33807288 | Social and ethical implications of HIV cure research |
| Q34331206 | Stem cell trials for cardiovascular medicine: ethical rationale |
| Q55426274 | Tackling treatment uncertainties together: the evolution of the James Lind Initiative, 2003-2013. |
| Q33484722 | Tailoring consent to context: designing an appropriate consent process for a biomedical study in a low income setting |
| Q35542896 | The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer. |
| Q46190745 | The Ethics of Health Care Delivery in a Pediatric Malaria Vaccine Trial: The Perspectives of Stakeholders From Ghana and Tanzania |
| Q38654279 | The Significance of Benefit Perceptions for the Ethics of HIV Research Involving Adolescents in Kenya |
| Q47280760 | The Therapeutic "Mis"conception: An Examination of its Normative Assumptions and a Call for its Revision. |
| Q34869484 | The ethics of HIV "cure" research: what can we learn from consent forms? |
| Q37189098 | The legal risks of returning results of genomics research |
| Q46357270 | The preventive misconception: experiences from CAPRISA 004. |
| Q36955261 | The role of therapeutic optimism in recruitment to a clinical trial in a peripartum setting: balancing hope and uncertainty |
| Q36514354 | Therapeutic Misconception in Psychiatry Research: A Systematic Review. |
| Q58570039 | Therapeutic Misperceptions in Early-Phase Cancer Trials: From Categorical to Continuous |
| Q39000016 | Therapeutic misconception correlates with willingness to participate in clinical drug trials among patients with epilepsy; need for better counseling |
| Q36949383 | Therapeutic misconception in research subjects: development and validation of a measure |
| Q34251038 | Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. |
| Q37986596 | Therapeutic misconception: hope, trust and misconception in paediatric research |
| Q30278493 | Those Responsible for Approving Research Studies Have Poor Knowledge of Research Study Design: a Knowledge Assessment of Institutional Review Board Members |
| Q35752023 | Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study |
| Q37969230 | Translational and clinical research in Singapore: ethical issues in a longitudinal study of the prodromal phase of schizophrenia |
| Q34249668 | Triggers for research ethics consultation |
| Q35242940 | Uncertainty and equipoise: at interplay between epistemology, decision making and ethics |
| Q50213573 | Understanding the 'therapeutic misconception' from the research participant's perspective. |
| Q34163982 | Unrealistic optimism in early-phase oncology trials |
| Q35359689 | What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent |
| Q33920607 | What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011. |
| Q40103793 | What should research participants understand to understand they are participants in research? |
| Q57988461 | What's Trust Got to Do With It? Trust and the Importance of the Research–Care Distinction |
| Q30275825 | When are clinical trials beneficial for study patients and future patients? A factorial vignette-based survey of institutional review board members |
| Q38832807 | Why take part in personalised cancer research? Patients' genetic misconception, genetic responsibility and incomprehension of stratification-an empirical-ethical examination |
| Q37982615 | Zinc finger nucleases: looking toward translation. |
Search more.